Alex Salmond investigation: FDA response
FDA General Secretary Dave Penman, responding to today’s announcement regarding the investigation into Alex Salmond, said:
“The decision today to set aside the investigation into former First Minister Alex Salmond is hugely regrettable. The women who have come forward in this case deserve to have their complaints investigated fairly and a conclusion reached.
”This decision relates to a procedural flaw in how the investigation was conducted. It does not challenge the process itself or make judgement on the substance of the case. In these circumstances, subject to the wishes of the complainants, we would call on the Scottish Government to re-investigate the complaints at the most appropriate time.”
Notes for editors
- The FDA is the union for senior managers and professionals in public service, representing more than 18,000 members at grades HEO and above. Membership includes senior civil servants, government policy advisors, prosecutors, diplomats, tax professionals, economists, solicitors and other professionals working across the Government and the NHS.
- The FDA (formerly the First Division Association) should be referred to simply as "The FDA" and can be described as "the senior public servants' union".
- The FDA can be found on Twitter @FDA_union and at www.fda.org.uk. General Secretary Dave Penman tweets as @FDAGenSec.
- For more information contact:
- FDA Communications Officer Tommy Newell on 020 7401 5588 or 07738 729 145 or email on firstname.lastname@example.org
- FDA Communications Officer Laura Gilbert on 020 7401 5589 or email on email@example.com
- The Scottish Government's public sector pay policy can be viewed here.
Latest News from
Welsh Government must revise funding to save our museums10/08/2020 12:25:00
The Senedd’s Culture, Welsh Language and Communications Committee has now published its report on the impact of the COVID-19 outbreak on heritage, museums and archives in Wales.
Welsh Government must act to ensure national treasures remain accessible to all, says FDA27/07/2020 10:20:00
The FDA has called on the Welsh Government to invest whatever is needed to protect Welsh national treasures and to ensure everyone in Wales continues to have access to their cultural history.
Parliament's restoration and renewal programme 'must not be derailed by political point scoring', says FDA17/07/2020 14:48:00
FDA National Officer for the House of Commons, Helen Kenny yesterday responded to reports that the Prime Minister has asked officials responsible for the restoration and renewal project to consider relocating Parliament to York.
'All we are asking is for the judiciary to follow government guidance'- FDA writes to the Lord Chief Justice14/07/2020 15:38:00
As the recognised union for prosecutors working in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with the Lord Chief Justice over the approach taken by some judges to applications from prosecutors to appear in court remotely.
Culture sector rescue package highlights failure of current funding models07/07/2020 12:25:00
The FDA represents staff working in museums and galleries across the UK.
Departure of Sir Mark Sedwill: FDA response29/06/2020 16:20:00
FDA General Secretary Dave Penman yesterday responded to the departure of Cabinet Secretary Sir Mark Sedwill.
FDA welcomes ‘historic moment for House of Commons’ as MPs put trust in independent process24/06/2020 16:20:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons debate on establishing the new Independent Expert Panel to deal with complaints of bullying and harassment against MPs.
Response to DFID and FCO merger17/06/2020 12:25:00
FDA National Officer Allan Sampson yesterday responded to the announcement that the Department for International Development (DFID) and the Foreign and Commonwealth Office (FCO) are to merge
HM Courts and Tribunals Service is failing to ensure safety, says FDA15/06/2020 13:15:00
As the recognised representatives of prosecutors and managers in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with HM Courts and Tribunals Service (HMCTS) about its approach to reopening courts across England and Wales.